Evidence map›Paper›PMID 29582728›Full record

ArticleThe American journal of tropical medicine and hygiene2018

Polymorphisms in the K13 Gene in

Zaydah R de Laurent, Lorna J Chebon, Luicer A Ingasia, Hoseah M Akala, Ben Andagalu, Lynette Isabella Ochola-Oyier, Edwin Kamau

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Polymorphism ofJournal of parasitology research · 2026
    Article
  3. Assessing the threat of artemisinin resistance: seasonal and ecological patterns ofFrontiers in cellular and infection microbiology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Increase ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Ten-Year Molecular Surveillance of Drug-ResistantFrontiers in cellular and infection microbiology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zaydah R de LaurentCenter for Biotechnology and Bioinformatics, University of Nairobi, Nairobi, Kenya.
Lorna J ChebonKenya Medical Research Institute/United States Army Medical Research Directorate-Kenya, Kisumu, Kenya.
Luicer A IngasiaKenya Medical Research Institute/United States Army Medical Research Directorate-Kenya, Kisumu, Kenya.
Hoseah M AkalaKenya Medical Research Institute/United States Army Medical Research Directorate-Kenya, Kisumu, Kenya.
Ben AndagaluKenya Medical Research Institute/United States Army Medical Research Directorate-Kenya, Kisumu, Kenya.
Lynette Isabella Ochola-OyierKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Edwin KamauKenya Medical Research Institute/United States Army Medical Research Directorate-Kenya, Kisumu, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of artemisinin (ART)-resistant parasites in Southeast Asia (SEA) threatens malaria control globally. Mutations in the Kelch 13 (K13)-propeller domain have been useful in identifying ART resistance in SEA. ART combination therapy (ACT) remains highly efficacious in the treatment of uncomplicated malaria in Sub-Saharan Africa (SSA). However, it is crucial that the efficacy of ACT is closely monitored. Toward this effort, this study profiled the prevalence of K13 nonsynonymous mutations in different malaria ecological zones of Kenya and in different time periods, before (pre) and after (post) the introduction of ACT as the first-line treatment of malaria. Nineteen nonsynonymous mutations were present in the pre-ACT samples (

Indexed as

GenotypePolymorphism, Single NucleotideAdolescentAdultAgedAntimalarialsChildChild, PreschoolDrug ResistanceHumansInfantKenyaMalaria, FalciparumMiddle AgedMutationPlasmodium falciparumAntimalarialsProtozoan Proteins

Identifiers

PMID29582728
PMCPMC5953360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.